Juvenile Polyposis Syndrome

Clinical Use

Use

Juvenile polyposis syndrome is a condition associated with the formation of numerous polyps in the gastrointestinal tract, specifically hamartomatous juvenile polyps. These polyps can lead to various symptoms including gastrointestinal bleeding, anemia, diarrhea, and abdominal pain. Individuals diagnosed with juvenile polyposis syndrome have an increased risk of developing colorectal cancer due to the potential for polyp formation. Early detection and management of polyps are crucial to prevent malignancy and manage symptoms effectively.

Special Instructions

Not provided.

Limitations

The genetic analysis for juvenile polyposis syndrome targets coding exons 1-11 of the BMPR1A and SMAD4 genes, along with adjacent intronic nucleotides. Gross deletion/duplication analysis is conducted to determine gene copy number. The methodologies used, such as next generation sequencing and multiplex ligation-dependent probe amplification, while highly effective, may not detect all possible variants. Intronic variants beyond 5 base pairs are not reported unless they are of clinical significance. Potential false-negative results are a possibility if there are areas of the genome not covered by current testing methods, or due to technical limitations like insufficient read depth in complex regions.

Test Details

Methodology

NGS (Targeted)

Biomarkers

BMPR1A, SMAD4

Gene

SNV/Indel

Mutation • Categorical (e.g., Positive / Negative / Indeterminate)

Result Turnaround Time

14-21 days

Specimen

Whole Blood

Volume

Not provided

Minimum Volume

Not provided

Collection Instructions

Please ensure specimen collection adheres to routine blood collection procedures. Contact your healthcare provider regarding any potential difficulties, particularly if there is a history of blood drawing complications.